Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Outset Medical (OM) Research & Development (2019 - 2026)

Outset Medical has reported Research & Development over the past 7 years, most recently at $5.1 million for Q4 2025.

  • Quarterly Research & Development fell 35.92% to $5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.2 million through Dec 2025, down 44.7% year-over-year, with the annual reading at $21.2 million for FY2025, 44.7% down from the prior year.
  • Research & Development was $5.1 million for Q4 2025 at Outset Medical, down from $5.4 million in the prior quarter.
  • Over five years, Research & Development peaked at $16.1 million in Q3 2023 and troughed at $5.1 million in Q4 2025.
  • The 5-year median for Research & Development is $10.3 million (2022), against an average of $10.1 million.
  • Year-over-year, Research & Development surged 68.34% in 2022 and then crashed 56.35% in 2025.
  • A 5-year view of Research & Development shows it stood at $11.4 million in 2021, then increased by 0.3% to $11.4 million in 2022, then increased by 9.51% to $12.5 million in 2023, then plummeted by 37.05% to $7.9 million in 2024, then plummeted by 35.92% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Research & Development are $5.1 million (Q4 2025), $5.4 million (Q3 2025), and $5.3 million (Q2 2025).